Tags

Type your tag names separated by a space and hit enter

[Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone].
Boll Chim Farm. 1989 Jun; 128(6):208-11.BC

Abstract

By reacting three quinolizidinylalkylamines with 1,4-naphtoquinone, 2,3-dichloronaphto-1,4-quinone and 1-chloroanthraquinone nine compounds were obtained which are of interest as antitumoral, antiviral, antibacterial and antiparasitic agents. These compounds, so far, have been tested against lymphocytic leukemia P 388 in mice and found inactive.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

ita

PubMed ID

2619988

Citation

Boido Canu, C, et al. "[Formulation and Antileukemic Activity of Quinolizidinylalkylaminic Derivatives of Naphthoquinone and Anthraquinone]." Bollettino Chimico Farmaceutico, vol. 128, no. 6, 1989, pp. 208-11.
Boido Canu C, Boido V, Sparatore F. [Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone]. Boll Chim Farm. 1989;128(6):208-11.
Boido Canu, C., Boido, V., & Sparatore, F. (1989). [Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone]. Bollettino Chimico Farmaceutico, 128(6), 208-11.
Boido Canu C, Boido V, Sparatore F. [Formulation and Antileukemic Activity of Quinolizidinylalkylaminic Derivatives of Naphthoquinone and Anthraquinone]. Boll Chim Farm. 1989;128(6):208-11. PubMed PMID: 2619988.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone]. AU - Boido Canu,C, AU - Boido,V, AU - Sparatore,F, PY - 1989/6/1/pubmed PY - 1989/6/1/medline PY - 1989/6/1/entrez SP - 208 EP - 11 JF - Bollettino chimico farmaceutico JO - Boll Chim Farm VL - 128 IS - 6 N2 - By reacting three quinolizidinylalkylamines with 1,4-naphtoquinone, 2,3-dichloronaphto-1,4-quinone and 1-chloroanthraquinone nine compounds were obtained which are of interest as antitumoral, antiviral, antibacterial and antiparasitic agents. These compounds, so far, have been tested against lymphocytic leukemia P 388 in mice and found inactive. SN - 0006-6648 UR - https://www.unboundmedicine.com/medline/citation/2619988/[Formulation_and_antileukemic_activity_of_quinolizidinylalkylaminic_derivatives_of_naphthoquinone_and_anthraquinone]_ DB - PRIME DP - Unbound Medicine ER -